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During animal cell cytokinesis, the spindle directs
contractile ring assembly by activating RhoA in a
narrow equatorial zone. Rapid GTPase activating
protein (GAP)-mediated inactivation (RhoA flux) is
proposed to limit RhoA zone dimensions. Testing
the significance of RhoA flux has been hampered
by the fact that the GAP targeting RhoA is not known.
Here, we identify M phase GAP (MP-GAP) as the pri-
mary GAP targeting RhoA during mitosis and cytoki-
nesis. MP-GAP inhibition caused excessive RhoA
activation inMphase, leading to the uncontrolled for-
mation of large cortical protrusions and late cytoki-
nesis failure. RhoA zone width was broadened by
attenuation of the centrosomal asters but was not
affected by MP-GAP inhibition alone. Simultaneous
aster attenuation and MP-GAP inhibition led to
RhoA accumulation around the entire cell periphery.
These results identify the major GAP restraining
RhoA during cell division and delineate the relative
contributions of RhoA flux and centrosomal asters
in controlling RhoA zone dimensions.
INTRODUCTION
Cytokinesis completes mitosis, partitioning the contents of a sin-
gle cell into two. In animal cells, cytokinesis is accomplished by
an equatorial contractile ring (Fededa and Gerlich, 2012; Green
et al., 2012) whose assembly is orchestrated by the anaphase
spindle-dependent formation of a narrow zone of active, plasma
membrane-associated RhoA (Bement et al., 2006; Piekny et al.,
2005; von Dassow, 2009). Active RhoA promotes contractile ring
assembly through effectors including the cytokinesis formin,
which nucleates actin filaments, and Rho kinase, which recruits
and activates myosin-II (Bement et al., 2006; Goode and Eck,
2007; Matsumura et al., 2011; Piekny et al., 2005). Classicmicro-496 Developmental Cell 26, 496–510, September 16, 2013 ª2013 Elsmanipulation experiments in echinoderm eggs demonstrated
that moving the spindle causes furrow regression and formation
of a new furrow above the spindlemidplane (Rappaport, 1985). A
recent rendition of this experiment with a fluorescent probe for
active RhoA suggested that furrow repositioning is mediated
by dynamic specification of the RhoA zone (Bement et al., 2005).
Rho family GTPases are activated by guanine nucleotide-
exchange factors (GEFs), which promote exchange of GDP for
GTP and target the GTPase to the membrane (Rossman et al.,
2005), and are inactivated by GTPase activating proteins
(GAPs) that enhance their intrinsically low hydrolysis rate (Tcher-
kezian and Lamarche-Vane, 2007). Specification of a narrow
equatorial zone of active RhoA is proposed to involve local acti-
vation of RhoA at the cell equator coupled to two mechanisms
that negatively regulate RhoA: global inactivation by a constitu-
tive GAP activity (RhoA flux) (Bement et al., 2006; Miller and
Bement, 2009) and suppression of cortical contractility at the
cell poles by the centrosomal microtubule asters (D’Avino
et al., 2005; Green et al., 2012; von Dassow, 2009). The RhoA
flux model predicts that reducing GAP-mediated RhoA turnover
will broaden the RhoA zone due to increased diffusion of active
RhoA generated by the equatorial stimulus through the mem-
brane (Bement et al., 2006).
The broadly conserved GEF Ect2 activates RhoA to promote
cell rounding (Matthews et al., 2012) and contractile ring assem-
bly (reviewed in Fededa and Gerlich, 2012; Green et al., 2012).
After chromosome segregation in anaphase, mechanisms that
localize Ect2 to the central spindle are thought to preferentially
activate RhoA at the cell equator (Fededa and Gerlich, 2012;
Green et al., 2012) and promote its loading onto the adjacent
equatorial plasma membrane (Su et al., 2011; Frenette et al.,
2012). By comparison, the relative contributions of the two nega-
tive regulatory mechanisms in limiting active RhoA to a narrow
equatorial zone during cytokinesis are less clear. Spindle
displacement in Caenorhabditis elegans embryos (Werner
et al., 2007), micromanipulation studies in grasshopper sper-
matocytes (Chen et al., 2008), direct imaging of myosin
dynamics in vertebrate cells (Zhou and Wang, 2008), and drug-
or laser-based ablation of astral microtubules (Bement et al.,
2005; Foe and von Dassow, 2008; Murthy and Wadsworth,evier Inc.
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Figure 1. The GAP Activity of RGA-3/4 Restrains RhoA Activity during Mitosis and Cytokinesis
(A) Schematics of a wild-type embryo (left), an ECT-2-depleted embryo (middle), and of the predicted effect of inhibiting the RhoA GAP (right).
(B) Of the 23 RhoGAPs in C. elegans, only three (CYK-4, RGA-3, and RGA-4) are embryonic lethal (Table S1).
(C) Left: schematics of CYK-4 and the cyk-4::gfp transgene. Right: immunoblot of worm extracts from the indicated transgenic strains probed for GFP and
a-tubulin as a loading control.
(D) Left: schematics of RGA-3 and RGA-4 and of the gfp::rga-3 transgene. Right: immunoblot of worm extracts from N2 control and indicated transgenic strains;
the strain expressing GFP::RGA-3 was homozygous for rga-3 and rga-4 deletions (rga-3/4D), whereas the strain expressing GFP::RGA-3GD was not.
(E) Differential interference contrast images during early and late cytokinesis for the indicated conditions.
(F) Graph plotting embryonic lethality, first division cytokinesis failure, and hypercontractility (>2 ingressions during mitosis). n = number of embryos.
(legend continued on next page)
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Control of RhoA Activity during Mitosis2008; von Dassow et al., 2009) have all supported the notion
that centrosomal asters suppress cortical contractility/RhoA
activation in their vicinity; however, the molecular basis for this
suppression is not known. Similarly, testing the RhoA flux model
requires identification of the major RhoA GAP during cell divi-
sion, whose identity has been unclear. The GAP domain of
CYK-4, a subunit of the centralspindlin complex that localizes
to the central spindle, has been proposed to inactivate RhoA
(Jantsch-Plunger et al., 2000), and a broader RhoA zone has
been reported in Xenopus embryos expressing GAP-dead
CYK-4 (Miller and Bement, 2009). However, work in C. elegans
has suggested that the CYK-4 GAP domain promotes, rather
than opposes, RhoA activation (Canman et al., 2008; Loria
et al., 2012). In addition, the primary in vitro targets of CYK-4
are Rac and Cdc42 rather than RhoA (Bastos et al., 2012;
Jantsch-Plunger et al., 2000; Kawashima et al., 2000;Minoshima
et al., 2003; Toure´ et al., 1998), and Rac inhibition partially sup-
presses the effects of inhibiting CYK-4 on cytokinesis (Canman
et al., 2008; D’Avino et al., 2004). This prior work suggests that
CYK-4 is likely not the major GAP activity countering Ect2-medi-
ated RhoA activation during cell division. p190RhoGAP, which
mediates actin cytoskeleton reorganization in response to
growth factor stimulation (Chang et al., 1995), integrin engage-
ment (Arthur and Burridge, 2001; Nakahara et al., 1998), and
v-Src-mediated transformation (Fincham et al., 1999), has also
been proposed to function during cytokinesis. However,
although its overexpression leads to increased multinucleation
in cultured vertebrate cells (Su et al., 2003; Su et al., 2009), the
effects of p190RhoGAP inhibition during mitosis have not been
characterized, and inhibition of the C. elegans p190RhoGAP
homolog, rga-5, does not cause mitotic defects (Kamath et al.,
2003; Rual et al., 2004; So¨nnichsen et al., 2005).
Here, we identify the primary GAP opposing RhoA activation
during mitosis and examine the roles of RhoA flux and the asters
in limiting RhoA zone dimensions during cytokinesis. An analysis
of candidate RhoGAPs in C. elegans highlighted the importance
of a pair of homologous RhoA GAPs, RGA-3, and RGA-4, that
were previously implicated in RhoA regulation during polarity
establishment (Schmutz et al., 2007; Schonegg et al., 2007). A
screen of the 67 predicted human RhoGAPs revealed a previ-
ously uncharacterized GAPwhose inhibition results in hypercon-
tractility specifically during mitosis/cytokinesis, leading us to
name it M phase GAP (MP-GAP). MP-GAP is a member of an
ancient metazoan RhoA GAP family that includes C. elegans
RGA-3/4 as distantly related orthologs. MP-GAP preferentially
targets RhoA in vitro, and the hypercontractility induced by
MP-GAP inhibition in vivo requires RhoA activation. In the
absence of centrosomal asters, MP-GAP inhibition broadens
the RhoA zone. However, in the presence of the asters, MP-
GAP inhibition accelerates the accumulation of contractile ring
proteins at the cell equator and promotes formation of large
cortical protrusions, but does not alter RhoA zone dimensions.
Thus, under normal conditions, MP-GAP-mediated RhoA flux
constrains RhoA activation to suppress protrusion formation,(G) Immunofluorescence of one-cell stage wild-type (left) and rho-1(RNAi) (right)
(H) Central plane confocal images of one-cell stage metaphase rga-3/4D embryos
each condition). Scale bars represent 10 mm.
See also Figure S1, Table S1, and Movies S1, S2, and S3.
498 Developmental Cell 26, 496–510, September 16, 2013 ª2013 Elsbut the dimensions of the equatorial RhoA zone are dominantly
specified by the centrosomal asters. In addition to identifying
the major RhoA GAP functioning during cell division, this effort
defines the relative roles of the two negative regulatory mecha-
nisms that shape the RhoA zone during cytokinesis.
RESULTS
The GAP Activity of RGA-3/4, but Not of CYK-4,
Restrains RhoA Activity in the Caenorhabditis elegans
Embryo
Ect2 inhibition prevents RhoA activation and cortical contractility
(for an example in the C. elegans embryo see Movie S1 available
online). We expected that inhibition of the major GAP opposing
RhoA activation during cytokinesis would lead to hypercontrac-
tility, a phenotype opposite of that resulting from Ect2 inhibition
(Figure 1A). C. elegans has 23 predicted RhoGAPs. Prior
genome-wide RNAi screens characterized 20 of these, and
we analyzed the remaining three (2RSSE.1, ZK669.1, and
Y34B4A.8). Of the 23 predicted Rho GAPs, only three were
required for embryonic viability following RNAi-mediated deple-
tion: CYK-4, RGA-3, and RGA-4 (Figure 1B; Table S1).
As notedabove,CYK-4 is implicated in cytokinesis, but itsGAP
activity is more likely to target Rac and/or Cdc42 than RhoA.
RGA-3/4 are homologous functionally redundant RhoA GAPs
shown to inactivateRhoAduring polarity establishment (Schmutz
et al., 2007; Schonegg et al., 2007). Prior work on all three pro-
teins has relied on depletions or temperature-sensitivemutations
that may affect other functions in addition to GAP activity.
To analyze the consequences of specifically inactivating GAP
activity, we engineered catalytically inactive (GAP-Defective)
mutant alleles (Rittinger et al., 1997) and determined their effects
on mitosis in the one-cell embryo. We established single-
copy insertion transgenic systems, expressing GFP-tagged
wild-type and GAP-Defective (GD) CYK-4 or RGA-3 under the
control of their endogenous regulatory sequences (Figures 1C
and 1D). The cyk-4 transgene was additionally engineered to be
resistant to a dsRNA targeting endogenous cyk-4 (Figure S1A).
As expected, depletion of endogenous CYK-4 in the absence
of a transgene resulted in embryonic lethality and cytokinesis
failure in the first division with partial cleavage furrow ingression
followed by regression. These phenotypes were rescued by
wild-type CYK-4::GFP but not CYK-4GD::GFP (Figures 1E and
1F; Movie S2) even though both were expressed at similar levels
(Figure 1C) and localized to the spindle midzone (data not
shown). Thus, inhibiting the GAP activity of CYK-4 results in
decreased contractility rather than the hypercontractility ex-
pected to result from a catalytically-defective major RhoA GAP.
Next, we analyzed the requirement for RGA-3/4 GAP activity.
A double deletion of rga-3 and rga-4 (Figure S1B) was maternal
effect embryonic lethal. Homozygous rga-3D rga-4D adults lay
embryos lacking maternally loaded protein (referred to as rga-
3/4D embryos) that are inviable (Figure 1F). The cortex in rga-
3/4D embryos is dramatically hypercontractile and 36% ofembryos stained with antibodies to RGA-3/4 (n > 12 for each condition).
expressing GFP-RGA-3GD after RNAi of the indicated genes (n > 7 embryos for
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Figure 2. Identification of a Human GAP that Opposes RhoA Activation during Mitosis
(A–C) HeLa cells were induced to express wild-type or constitutively active (Q63L) GFP::RhoA for 16 hr prior to imaging. (A) Bright field images. Scale bar
represents 10 mm. (B and C) Graphs plotting the percentage of mitotic cells expressing each RhoA variant that had large protrusions (B) or exhibited cytokinesis
failure (C). Error bars are SD from two or three independent experiments. n = total number of cells.
(D) Graph plotting the mean percentage of mitotic cells with large protrusions across two (38 genes) or three (33 genes) independent experiments following
knockdown of each of the predicted human RhoGAPs. Mitotic cells from all four siRNAs targeting each gene were pooled. Error bars represent SD.
(E) Schematics of three human RhoGAPs with a domain architecture similar to C. elegans RGA-3.
(legend continued on next page)
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Control of RhoA Activity during Mitosisembryos fail the first cytokinesis (Figures 1E and 1F). This hyper-
contractility was suppressed by inhibiting RhoA activation using
ECT-2 depletion (Figure S1C). Embryonic lethality, hypercon-
tractility, and first cytokinesis failure in rga-3/4D embryos were
all rescued by wild-type GFP::RGA-3 but not GFP::RGA-3GD
(Figures 1E and 1F; Movie S3) even though both proteins were
expressed at comparable levels (Figure 1D). Thus, RGA-3/4
GAP activity is essential to prevent hypercontractility during
mitosis in the early C. elegans embryo.
RGA-3/4 localized to the cortex and the centrosomal region
during mitosis and cytokinesis (Figures 1G, S1D and S1E), as it
does during embryo polarization (Schonegg et al., 2007), and
this localization depended on RhoA (RHO-1 in C. elegans; Fig-
ure 1G) and the RhoA GEF ECT-2 (Figure S1D), but not on
CDC-42 or Rac (CED-10; data not shown). Although mutating
the arginine finger abolishes the ability of theGAP domain to pro-
mote GTP hydrolysis, it does not prevent binding of the GAP
domain to its target GTPase (Ahmadian et al., 1997; Graham
et al., 1999; Leonard et al., 1998). Consistent with this,
GFP::RGA-3GD was strongly enriched on the cortex compared
to wild-type GFP::RGA-3 (Figures 1H and S1F; GFP::RGA-3GD
accumulates asymmetrically on the anterior cortex due to em-
bryo polarity) and this localization depended on RHO-1 and the
ECT-2 GEF (Figures 1H and S1G), but not on Cdc42 (Figure 1H)
cdc-42(RNAi) or Rac (Figure 1H) (ced-10 and rac-2(RNAi)).
The RhoA-dependent cortical accumulation of GAP-Defective
RGA-3/4 provides strong in vivo evidence that RGA-3/4 GAP
activity specifically targets RhoA. We conclude that the GAP
activity of RGA-3/4, but not of CYK-4, counters RhoA activation
during the early embryonic divisions of C. elegans.
Identification of a Conserved M Phase GAP Family that
Controls Cortical Contractility during Mitosis and
Cytokinesis
Sequence searches with RGA-3/4 failed to identify highly related
orthologs outside of nematodes other than highlighting the pres-
ence of a RhoGAP domain. To identify human GAPs that control
RhoA activity during mitosis and cytokinesis, we therefore took
an unbiased screening approach. To define the phenotypic
fingerprint of excessive RhoA activation during mitosis and cyto-
kinesis, we first generated isogenic HeLa cell lines expressing
wild-type or constitutively active GFP::RhoA (RhoAQ63L) under
the control of an inducible promoter. In contrast to mitotic cells
expressing wild-typeGFP::RhoA, nearly all mitotic cells express-
ing constitutive active GFP::RhoAQ63L formed large cortical
protrusions (Figures 2A and 2B). Approximately 20% of cells ex-
pressing GFP::RhoAQ63L also failed cytokinesis (Figure 2C).
These results suggested that protrusion formation is a hallmark
of excessive RhoA activation in mitotic cells.
We next targeted each of the 67 known human Rho GAPs with
four independent siRNA oligos and quantified the percentage of
mitotic cells with large protrusions. Three genes with known(F) Images of unsynchronized HeLa cells stained for DNA and RhoA after trea
Arrowheads point to small blebs, which are present in controls; arrows poi
represents 10 mm.
(G) Phylogenetic tree of a GAP domain alignment highlighting conservation of
numbers see Figure S2D).
See also Figure S2.
500 Developmental Cell 26, 496–510, September 16, 2013 ª2013 Elsroles in mitosis (Kif11 [Eg5], PLK1, and MKLP1) were also
included in the screen to control for the efficacy of the siRNA
procedure. Cells were fixed and stained for DNA and RhoA
and image stacks were acquired for multiple fields per well using
a high content imaging system. The assay was performed three
times, and the mean mitotic cells analyzed per gene was 43
(range 23–77). In this screen, inhibition of only one previously
uncharacterized human GAP, ARHGAP11A, led to a significant
increase in protrusion formation (Figures 2D and 2F).
ARHGAP11A has a domain structure similar to RGA-3/4, with
an N-terminal GAP domain in the context of a larger protein
lacking other functional motifs (Figure 2E). This architecture is
present in only three (ARHGAP11A, FAM13A, and FAM13B) of
the 67 predicted human RhoGAPs. To determine if there is
any redundancy between the three N-terminal GAP domain
RhoGAPs, we analyzed protrusion formation after depleting
FAM13A and FAM13B individually and in combination with
each other and ARHGAP11A (Figures 2F and S2E). Codepletion
of FAM13A, FAM13B, or both along with ARHGAP11A did not
enhance the ARHGAP11A phenotype (Figure S2E), suggesting
that only ARHGAP11A plays a significant role in limiting protru-
sion formation in mitotic cells.
Humans, but not other primates, have a second homologous
gene 2 Mb away from ARHGAP11A, called ARHGAP11B,
which is likely derived from a local duplication on chromosome
15 (Riley et al., 2002). The ARHGAP11B locus directs expression
of a truncated 267 aa protein homologous to the ARHGAP11A
GAP domain (Figures S2A and S2B). Our siRNA is outside the
region conserved between the two genes and targets only
ARHGAP11A (Figure S2C). These results suggest that
ARHGAP11A is the critical Rho GAP that counters RhoA activa-
tion during mitosis in human cells. Based on the phenotypic
analysis described below we decided to name ARHGAP11A,
MP-GAP for M Phase GAP. Blast searches and sequence align-
ments based on the GAP domain (Figure 2G) revealed MP-GAP
homologs in vertebrates, insects (but not in Drosophila), the
sea anemone (phylum Cnidaria), and the primitive metazoan
Trichoplax adherens (phylum Placozoa); C. elegans RGA-3/4
appear to be evolutionarily distant members of the ancient MP-
GAP family (Figures 2G and S2D).
We next analyzed MP-GAP localization by engineering a
HeLa cell line expressing MP-GAP::GFP from an integrated
BAC (in parallel, we tested two commercial antibodies but
neither worked for immunofluorescence or immunoblotting).
MP-GAP::GFP was enriched on the cortex from prophase
through anaphase and concentrated in the nucleus from late
telophase through interphase (Figure 3A). The MP-GAP::GFP
cell line also enabled identification of a single siRNA oligo that
efficiently reduced protein levels by >95% (Figure 3B).
Consistent with its sequestration in the nucleus, the mor-
phology of interphase cells appeared normal following MP-
GAP depletion (Figure S3A). To confirm this observation, wetment with a control siRNA or pooled siRNAs targeting the indicated GAPs.
nt to large protrusions resulting from ARHGAP11A knockdown. Scale bar
the MP-GAP family in invertebrates and primitive metazoans (for accession
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Control of RhoA Activity during Mitosisgenerated a HeLa cell line expressing Anillin::GFP from an
integrated BAC and performed time-lapse imaging. When
Anillin::GFP was in the nucleus during interphase, the mor-
phology of MP-GAP siRNA cells was indistinguishable from con-
trols (Figures 3C and 3D). The timing of mitotic events was also
similar in control and MP-GAP siRNA-treated cells (Figures
S3B and S3C). However, MP-GAP-depleted cells began to
form large cortical protrusions concomitant with mitotic cell
rounding. Protrusions were at least 2- to 3-fold bigger than blebs
in control anaphase cells, were more stable than blebs, had a
narrow opening to the cell body, were enriched for cortical
Anillin::GFP (Figure 3C) and filamentous actin (Figure S3D), and
were present throughout mitosis and cytokinesis (Figures 3C
and 3D; Movies S4 and S5). Quantification of the spatial distribu-
tion of protrusions in fixed early anaphase cells did not reveal a
spatial bias for their formation on the equatorial versus polar
cortex (Figure 3E).
Next, we determined whether MP-GAP inhibition affected
Ect2 localization by monitoring Ect2::GFP expressed from an in-
tegrated BAC. Ect2::GFP localized to the spindle midzone and
the equatorial plasma membrane during anaphase and cytoki-
nesis in a similar fashion in control and MP-GAP-depleted cells
(Figure 3F), suggesting that MP-GAP inhibition leads to protru-
sion formation by failing to inactivate RhoA rather than altering
the pattern of RhoA activation.
We next monitored cytokinesis following MP-GAP inhibition in
two different HeLa cell lines (Figure 3G). In HeLa cells expressing
a GFP-tagged plasma membrane marker, cytokinesis never
failed following treatment with control siRNA, but failed 18% of
the time when MP-GAP was depleted. In most cases (15%),
this was a late failure, with the furrow regressing 90 min after
anaphase onset (Figure 3G); however, a small percentage of
cells (3%) exhibited an early failure in which they failed to form
a cleavage furrow. HeLa cells expressing Ect2::GFP were sensi-
tized to early failure, potentially due to excess RhoA activation;
5% exhibited early failure when treated with control siRNA
and this was increased to 17% following treatment with MP-
GAP siRNA. Cumulatively, these results suggest that MP-GAP-
inhibited cells are prone to cytokinesis failure. In a nonsensitized
background, the majority of MP-GAP-inhibited cells assemble a
contractile ring that constricts, but at an appreciable frequencyFigure 3. MP-GAP Controls Cortical Dynamics during Mitosis and Cyt
(A) HeLa cells expressing BAC-integrated MP-GAP::GFP fixed at different cell cy
(B) Immunoblot of HeLa cells expressing BAC-integratedMP-GAP::GFP treatedw
were loaded to quantify depletion level. Alpha-tubulin served as a loading contro
(C) HeLa cells expressing BAC-integrated Anillin::GFP filmed starting 48 hr after tr
confocal fluorescence (bottom) images are shown.
(D) Graph of the percentage of cells with large protrusions in interphase (n = 2 exp
experiments). Error bars represent SD. Total number of cells analyzed: control si
siRNA (55 interphase, 140 prometaphase/metaphase, 140 anaphase).
(E) Graph showing the spatial distribution of protrusions in early anaphase fix
experiments).
(F) Fluorescence confocal images of HeLa cells expressing BAC-integrated Ect2::
after anaphase onset.
(G) Representative brightfield and confocal fluorescence images from time-laps
Ect2::GFP and treated with control or MP-GAP siRNA as indicated. Imaging wa
anaphase onset. Graph shows percentage of early and late cytokinesis failure f
(Ect2::GFP) independent experiments. The total number of cells analyzed was: M
siRNA, 159 MP-GAP siRNA). Scale bars represent 10 mm.
See also Figure S3 and Supplemental Experimental Procedures.
502 Developmental Cell 26, 496–510, September 16, 2013 ª2013 Elscells fail to complete abscission. In a sensitized background,
the rate of early failure is substantial. We conclude that MP-
GAP suppresses the formation of cortical protrusions during
mitosis and cytokinesis and is required to ensure successful
cytokinesis.
MP-GAP Suppresses Cortical Hypercontractility by
Targeting RhoA
To determine how MP-GAP controls cortical contractility in
mitotic cells, we first tested the role of its GAP activity by using
Flp-mediated recombination to generate HeLa cell lines with sin-
gle copy, tetracycline-inducible, siRNA-resistant transgenes ex-
pressing GFP::MP-GAP or an equivalent GAP-Defective version.
Both proteins were expressed at similar levels (Figure 4A) and
localized to the cortex (Figure 4B). Expression of wild-type, but
not GAP-Defective MP-GAP, suppressed protrusion formation
during mitosis resulting from depletion of endogenous MP-
GAP (Figure 4B). Thus, the ability of MP-GAP to prevent cortical
hypercontractility during mitosis requires its GAP activity.
MP-GAP is predicted to target a Rho family GTPase. To deter-
mine whether it targets RhoA, Rac1, or Cdc42 we purified the
GAP domain of MP-GAP from Escherichia coli (Figure 4C) and
analyzed its activity in vitro. In an assay monitoring phosphate
generated by GTP hydrolysis, the purified MP-GAP GAP domain
showed high activity toward RhoA compared to Cdc42 or Rac1
(Figure 4C). Consistent with this in vitro finding, staining of fixed
cells for DNA and RhoA revealed that metaphase cells depleted
of MP-GAP had higher levels of RhoA at the cell cortex than con-
trol cells (Figure 4D).
If MP-GAP targets RhoA, as suggested by the in vitro analysis
and measurements of cortical RhoA levels, the protrusions
observed following its inhibition should be suppressed by
reducing RhoA activation. To test this prediction, we analyzed
protrusion formation following three different perturbations ex-
pected to prevent RhoA activation: treatment with C3 exoen-
zyme (Figures 4E and S4A), depletion of the Ect2 GEF (Figures
4F and S4B), and inhibition of PLK1 with the inhibitor BI2536
(Figures 4G and S4D). Previous work has shown that PLK1 is
required for RhoA activation and contractile ring assembly
(Figure S4C; Brennan et al., 2007; Burkard et al., 2007, 2009;
Petronczki et al., 2007; Wolfe et al., 2009). All three treatmentsokinesis
cle stages and stained for DNA, GFP, and microtubules.
ithMP-GAP siRNA#1 or a control siRNA for 48 hr. Serial dilutions of control cells
l.
ansfection with control or MP-GAP siRNA. Representative bright field (top) and
eriments), prometaphase/metaphase (n = 7 experiments), and anaphase (n = 7
RNA (55 interphase, 245 prometaphase/metaphase, 263 anaphase), MP-GAP
ed cells stained for RhoA and DNA. (40 protrusions from two independent
GFP 48 hr after transfection with control or MP-GAP siRNA. Times are minutes
e sequences of HeLa cells expressing Membrane::GFP (MyrPalm:mEGFP) or
s initiated 8 hr after release from a thymidine block. Times are minutes after
or each condition. Error bars represent SD of two (Membrane::GFP) or three
embrane::GFP (95 control siRNA, 90 MP-GAP siRNA); Ect2::GFP (179 control
evier Inc.
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Figure 4. MP-GAP Suppresses Cortical Hypercontractility by Targeting RhoA
(A) Immunoblot of stable isogenic HeLa cell lines expressing GFP::MP-GAP or GAP-deficient GFP::MP-GAPGD probed with antibodies to GFP and a-tubulin.
(B) Left: immunofluorescence images of a control cell line or cell lines expressing GFP::MP-GAP or GFP::MP-GAPGD after transfection with MP-GAP siRNA.
Cells were stained for DNA, RhoA, and GFP. Right: graph showing the mean percentage of mitotic cells with protrusions. Error bars represent SD of three
independent experiments. Total number of cells analyzed: control siRNA (170 No transgene), MP-GAP siRNA (158 No transgene; 170 GFP::MP-GAP;
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Control of RhoA Activity during Mitosissuppressed protrusion formation inMP-GAP-depleted cells (Fig-
ures 4E–4G) and prevented contractile ring assembly in both
control and MP-GAP-depleted cells. Interestingly, treatment
with the Rho kinase inhibitor Y27632 (Figures 4H and S4E) sup-
pressed protrusion formation without blocking contractile ring
assembly. Staining with an antibody to phosphorylated myosin
light chain (P-MLC) revealed that, in addition to enrichment in
the contractile ring, P-MLC was concentrated at the base of
the protrusions in MP-GAP-inhibited cells (Figure S4F). A
requirement for myosin phosphorylation in protrusion formation
may underlie the potent suppression observed following inhibi-
tion of Rho kinase. Taken together, the in vitro and in vivo data
support the conclusion that MP-GAP suppresses protrusion for-
mation in mitotic cells by promoting RhoA GTP hydrolysis.
MP-GAP Inhibition Accelerates RhoA Accumulation but
Does Not Alter RhoA Zone Dimensions
We next tested the consequence of inhibiting MP-GAP on the
dimensions of the equatorial RhoA zone. In the RhoA flux model,
reducing GAP-mediated RhoA turnover is predicted to broaden
the RhoA zone (Figure 5A) (Bement et al., 2006). The RhoA zone
can be monitored in fixed cells by staining for RhoA (Yonemura
et al., 2004). In living cells, the RhoA zone can be indirectly moni-
tored by following the recruitment of Anillin, which binds to and
colocalizes with active RhoA (Piekny and Glotzer, 2008).
We first used time-lapse imaging to monitor the dynamics of
Anillin::GFP recruitment (Figure 5B). Zone width was measured
at cytokinesis onset (when the first bending of the cortex was
evident, 9 min after anaphase onset) by generating a scan of
Anillin::GFP fluorescence intensity along a 5 pixel-wide line
that encompassed the cortex from pole to pole (excluding blebs
and protrusions). This analysis revealed that the width of the
Anillin::GFP zone was not significantly different between control
and MP-GAP siRNA-treated cells (p = 0.20; Figure 5C). To
analyze the timing of Anillin zone formation, we measured the
mean Anillin::GFP fluorescence intensity over the central region
of the cell (from 4 to +4 mm from the cell center) at 3, 6, and
9 min after anaphase onset (Figure 5D). In control cells,
Anillin::GFP was first detected at the cell equator 6 min after
anaphase onset. By contrast, in MP-GAP siRNA-treated cells,
accumulation was evident by 3 min after anaphase onset and
Anillin::GFP had accumulated to a significantly greater extent
at the 6min time point than in controls (Figure 5D). Thus, whereas(C) Left: Coomassie-stained gel of purified GAP domain used in the in vitro GA
absorbance at 650 nm, after incubation of purified MP-GAP domain or control buf
experiments; error bars represent SD.
(D) Right: immunofluorescence images of synchronized HeLa cells treated with
stained for DNA and RhoA. Left: graph of themaximumRhoA fluorescence intensi
siRNA) measured from 20 pixel wide linescans. The total number of linescans wa
n = 50). P values are from Student’s t tests. Error bars represent SEM.
(E–H) Representative images of HeLa cells fixed and stained for DNA and RhoA.
bars represent SD. Treatment protocols for each inhibitor/siRNA are outlined in F
total number of analyzed cells in two independent experiments was control si
transfectedwith control or MP-GAP siRNA for 24 hr followed by a second siRNA tra
three independent experiments was: first siRNA control (second siRNA: 64 contro
cells synchronized and treated with the PLK1 inhibitor BI2536 during anaphase. T
siRNA (114 DMSO; 84 BI2536), MP-GAP siRNA (130 DMSO; 151 BI2536). (H) HeL
analyzed cells in two independent experiments was control siRNA (34 DMSO; 37
See also Figure S4.
504 Developmental Cell 26, 496–510, September 16, 2013 ª2013 Elszone dimensions were unchanged, Anillin recruitment was
accelerated following MP-GAP inhibition.
To analyze RhoA directly in the absence of excessive cortical
contractility, we next measured the width of the RhoA zone in
synchronized, fixed HeLa cells that were treated with blebbista-
tin to inhibit myosin-II-mediated cortical contractility (Figure 5E)
(Straight et al., 2003). The measurements were performed on
early anaphase cells that had either no cleavage furrow (blebbis-
tatin-treated and DMSO-treated control) or a slight bend to the
cortex (DMSO-treated control). Although the RhoA zone was
slightly wider in blebbistatin-treated cells than in DMSO-treated
controls, RhoA zone dimensions were not significantly different
between control andMP-GAP-depleted cells for either condition
(Figure 5F; DMSO p = 0.67, blebbistatin p = 0.37). Treatment of
cells with blebbistatin reduced the size and number of protru-
sions inMP-GAP-inhibited cells, but did not completely eliminate
them (Figure 5F). This is likely because blebbistatin was added at
a timewhen numerous protrusions were already present; consis-
tent with this, treatment of unsynchronized MP-GAP-depleted
HeLa cells with blebbistatin for 1 hr completely blocked protru-
sion formation (data not shown). We conclude that modulating
RhoA flux by inhibitingMP-GAP accelerates Anillin accumulation
at the cell equator but does not affect the spatial dimensions of
the RhoA or Anillin zones.
RhoA Zone Dimensions Are Dominantly Specified by the
Centrosomal Microtubule Asters
The results above indicate that inhibiting MP-GAP-mediated
RhoA flux enhances RhoA activation, leads to numerous large
protrusions, and accelerates RhoA accumulation at the cell
equator, but surprisingly does not alter contractile ring-associ-
ated RhoA zone dimensions. Thus, rather than being limited by
RhoA diffusion, RhoA zone dimensions must be matched to
the dimensions of the spindle by another mechanism. A likely
possibility based on prior work is that the centrosomal asters
specify RhoA zone dimensions by preventing the accumulation
of active RhoA and/or contractile ring proteins in their vicinity;
this mechanism must be sufficiently robust to overcome
enhanced RhoA activation. This model predicts that inhibiting
assembly of centrosomal microtubules should lead to a broader
RhoA zone, whereas enhancing the assembly of astral microtu-
bules should have the opposite effect, narrowing the zone of
RhoA and contractile ring protein accumulation. Prior work inP assay. Right: graph showing production of free phosphate, monitored by
fer with RhoA, Rac1, or Cdc42. Numbers are the mean from three independent
control or MP-GAP siRNA, arrested in metaphase with MG132, and fixed and
ty on the cell cortex (control andMP-GAP siRNA) or in the protrusions (MP-GAP
s: control siRNA (cortex, n = 48), MP-GAP siRNA (cortex, n = 64; protrusions,
Graphs display the mean percentage of anaphase cells with protrusions. Error
igures S4A–S4E. (E) HeLa cells treated for 6 hr with the RhoA inhibitor C3; the
RNA (30 DMEM; 37 C3), MP-GAP siRNA (49 DMEM; 46 C3). (F) HeLa cells
nsfection (control or Ect2 siRNA) for 24 hr. The total number of analyzed cells in
l; 67 Ect2); first siRNA MP-GAP (second siRNA: 69 control; 69 Ect2). (G) HeLa
he total number of cells analyzed in two independent experiments was: control
a cells treated for 1 hr with the Rho kinase inhibitor Y27623. The total number of
Y27623), MP-GAP siRNA (61 DMSO; 33 Y27623). Scale bars represent 10 mm.
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Figure 5. MP-GAP Inhibition Accelerates RhoA Accumulation but Does Not Alter RhoA Zone Dimensions along the Anaphase Spindle
(A) Schematic of the RhoA flux model.
(B) Time-lapse confocal fluorescence images of Anillin::GFP HeLa cells transfected with control or MP-GAP siRNA.
(C) Left: central plane confocal image and schematic illustrating the method used to measure the width of the Anillin::GFP zone. Right: graph plotting the width of
the Anillin::GFP zone in cells transfectedwith control or MP-GAP siRNA. Data from two independent experiments were pooled. n = number of linescans analyzed.
Error bars represent SEM.
(D) Mean Anillin::GFP fluorescence intensity in an 8 mmwide equatorial region 3, 6, and 9 min after the last metaphase frame. Mean fluorescence intensities were
measured from cortical linescans as described in (C) and were normalized to the mean intensity in controls at 9 min (set to 100%). Data from two independent
experiments were pooled. The total number of cells analyzed was: control siRNA n = 21, MP-GAP siRNA n = 19. Error bars represent SEM p values are from
Student’s t tests.
(E) Experimental scheme used to treat cells with blebbistatin at anaphase onset.
(F) Width of the RhoA zone in fixed early anaphase DMSO and blebbistatin-treated cells measured as described in (C). n = number of linescans analyzed. Error
bars represent SEM. Scale bars represent 10 mm.
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Control of RhoA Activity during Mitosissea urchin embryos and porcine epithelial cells has shown that
eliminating dynamic astral microtubules results in a broader
zone of active RhoA (Bement et al., 2005; Foe and von Dassow,
2008; Murthy and Wadsworth, 2008; von Dassow et al., 2009).
We confirmed that this was also true in HeLa cells following treat-
ment with a low dose (10 nM) of nocodazole for 10 min during
anaphase. This treatment disrupted astral microtubules, and
led to an30% reduction spindle midzone length, but preserved
the microtubule bundles in the central spindle (Figures 6A–6C).
Notably, disruption of the astral microtubules led to a 1.5- to
2-fold increase in the mean width of the RhoA and Anillin zones
(Figures 6D–6F).
Because eliminating the centrosomal asters is a severe pertur-
bation with the potential to alter RhoA regulation via ectopic
means, for example by releasing microtubule-bound GEF-H1
(Chang et al., 2008), we also examined the effects on the RhoA
zone of augmenting the asters via MCAK inhibition. MCAK is a
kinesin that inhibits microtubule assembly (Desai et al., 1999).
Treatment of cells with MCAK siRNA has previously been shown
to result in longer astral microtubules (Rankin and Wordeman,
2010). MCAK siRNA did not disrupt midzone assembly or
PLK1 recruitment to the central spindle (Figure 6A) and spindle
midzone dimensions in MCAK siRNA-treated cells were not
significantly different from controls (Figures 6B and 6C; p =
0.9). However, MCAK inhibition led to a modest but significant
(p < 0.001) reduction in the width of both the RhoA and Anilin
zones compared to controls. Quantification of total fluorescence
intensity in the RhoA and Anillin zones also revealed that
both were significantly reduced by MCAK inhibition (p <
0.0001, Figure S5), whereas total RhoA and Anillin in low dose
nocodazole-treated cells were not significantly different from
controls (RhoA p = 0.52, Anillin p = 0.06, Figure S5). We conclude
that the dimensions of the equatorial RhoA zone, although not
altered by the MP-GAP inhibition-induced increase in active
RhoA, can be increased or decreased by eliminating or aug-
menting the centrosomal asters, respectively.
We next testedwhetherMP-GAP-mediated RhoA flux controls
RhoA zone dimensions in the absence of the asters. Control and
MP-GAP-inhibited cells expressing Anillin::GFP were imaged
starting at metaphase and nocodazole was added immediately
after thecells enteredanaphase (2–3minafter the lastmetaphase
frame). Consistent with the results in fixed cells, eliminating
the asters by nocodazole addition broadened the Anillin::GFP
zone (Figures 6G–6I). When asters were attenuated in MP-
GAP-inhibited cells, the Anillin::GFP zone was broadened even
further, with Anillin::GFP accumulating around the entire periph-
ery of the cell (Figures 6G–6I). These results indicate that MP-
GAP-mediated flux is essential to limit the RhoA zone to the cell
equator when the aster-based restriction mechanism is compro-
mised. In the absence of the two independent mechanisms that
limit RhoAaccumulation to the cell equator, Anillin::GFPaccumu-
lated uniformly on the cortex. However, when present, the asters
dominantly specify the RhoA zone dimension, rendering it
insensitive to fluctuations in the level of RhoA activation.
DISCUSSION
Both GAP-mediated RhoA flux (Bement et al., 2006; Miller and
Bement, 2009) and inhibitory signals from the centrosomal506 Developmental Cell 26, 496–510, September 16, 2013 ª2013 Elsasters (Bement et al., 2005; Foe and von Dassow, 2008; Murthy
andWadsworth, 2008; von Dassow et al., 2009) are proposed to
limit the dimensions of the equatorial RhoA zone. Investigation of
how these two mechanisms are integrated was limited by the
fact that the primary GAP opposing RhoA activation during cell
division was not known. Here, we identify MP-GAP, a member
of an ancient metazoan RhoGAP family, as a key regulator of
RhoA during cell division.
MP-GAP limits RhoA activity throughout mitosis to stabilize
the cortex and prevent the formation of large protrusions. In
the absence of the centrosomal microtubule asters, MP-GAP
also restricts RhoA zone dimensions as predicted by the RhoA
flux model. However, in the presence of the centrosomal asters,
the dimensions of the equatorial RhoA zone are not affected by
MP-GAP inhibition (summarized in Figure 7). These results
suggest that when present, the centrosomal asters dominantly
control RhoA zone dimensions. Previous work has shown that
eliminating dynamic astral microtubules leads to a broader
zone of active RhoA and contractile ring protein accumulation
(Bement et al., 2005; Foe and von Dassow, 2008; Murthy and
Wadsworth, 2008; von Dassow et al., 2009). As eliminating cen-
trosomal asters could upregulate RhoA via ectopic means, such
as release of a microtubule-bound RhoA activator (Chang et al.,
2008), we also showhere that augmenting centrosomal asters by
RNAi of the microtubule disassembly enzyme MCAK (Desai
et al., 1999; Rankin and Wordeman, 2010) has the opposite
effect. Although the molecular basis for the control of RhoA
zone by the asters is not known, the fact that RhoA zone dimen-
sions are not affected by MP-GAP inhibition suggests that the
aster-based mechanism does not involve activating MP-GAP
in a spatially patterned fashion.
Rather than leading to a change in RhoA zone dimensions as
measured along the length of the spindle, compromising RhoA
inactivation by inhibiting MP-GAP leads to the dynamic forma-
tion of large ectopic protrusions, a phenotype similar to that
resulting from expression of constitutively active RhoA. We pro-
pose that MP-GAP opposes RhoA activation wherever it occurs.
At the cell equator, MP-GAP slows but does not prevent RhoA
activation, likely because active RhoA at the cell equator is
maintained by persistent Ect2 GEF activity resulting from the
proximity of the central spindle. Nascent protrusions located
anywhere on the cell surface have a narrow base and loop out
away from the cell body; thus, the cortex within protrusions
would presumably not be directly subject to either aster-based
inhibition or to persistent Ect2 GEF signaling. Nascent protru-
sions would normally be terminated by MP-GAP, which would
inactivate GTP-bound RhoA that is not being actively replen-
ished. In the absence of MP-GAP, active RhoA that diffused in
from other parts of the cortex would not be inactivated, and
protrusion geometry would protect the extruded cortex from
aster-based inhibition. This could initiate the accumulation of
contractile ring proteins that in turn, via positive feedback, would
further promote RhoA activation. Despite the fact that aster-
based inhibition maintains the general pattern of RhoA activation
along the spindle, MP-GAP inhibition results in a significant level
(20%) of cytokinesis failure, largely due to failure of abscission
rather than contractile ring assembly or constriction. A role
for MP-GAP-mediated downregulation of RhoA in facilitating
abscission is plausible, because RhoA localizes to the midbodyevier Inc.
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Figure 6. MP-GAP-Mediated RhoA Flux Specifies RhoA Zone Dimensions when the Centrosomal Microtubule Asters Are Absent
(A) Immunofluorescence images of control, MCAK siRNA, and low dose nocodazole-treated cells stained for DNA, PLK1, and a-tubulin.
(B) Measurement of midzone length from DNA fluorescence images of fixed early anaphase cells using a 50 pixel wide line scan and measuring the distance
between the two peaks of DNA fluorescence intensity.
(C) Graph of midzone length for control, MCAK siRNA-treated, and low dose nocodazole-treated cells. n = number of cells scored. Error bars represent SEM.
(legend continued on next page)
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Figure 7. MP-GAP Controls RhoA Zone Formation in the Absence of
the Centrosomal Asters
In control cells, RhoA zone dimensions are dominantly specified by the cen-
trosomal asters. MP-GAP inhibition does not increase RhoA zone dimensions
when the asters are present, but it does lead to the formation of large pro-
trusions. In the absence of the centrosomal asters, MP-GAP inhibition
broadens the equatorial RhoA zone indicating that RhoA zone dimensions are
controlled by MP-GAP-mediated RhoA flux.
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Control of RhoA Activity during Mitosisring (Gai et al., 2011; Hu et al., 2012) and, along with anillin, con-
centrates at the sites on either side of the midbody where
ESCRT-mediated cleavage occurs (Hu et al., 2012).
Our results suggest a ‘‘dominant suppression’’ model in which
RhoA activation and diffusion are dominantly suppressed
outside of a specified equatorial zone (Figure 7). Dominant sup-
pression by the asters would have significant advantages over
zone specification through a flux-based mechanism. First, it
would make the cell relatively insensitive to the precise localiza-
tion of the signal activating RhoA. This could explain, for
example, why displacing the RhoA GEF Ect2 from its location
on the central spindle does not have a dramatic effect on cytoki-
nesis (Chalamalasetty et al., 2006). Dominant suppression would
also allow rapid achievement of the state observed in vivo, where
the profile of active RhoA resembles a step function with little to
no active RhoA at the cell poles and maximal activation within an
equatorial region. Feedback, in which the assembly of contrac-
tile ring proteins such as Anillin promotes RhoA activation
(Piekny and Glotzer, 2008; Frenette et al., 2012), could also
contribute to the rapid, step-like accumulation of contractile
ring proteins within a central zone.
In summary, identification of the MP-GAP family that opposes
RhoA activation during cell division has enabled comparison of(D) Anaphase immunofluorescence images of cells treated as indicated and stai
(E and F) Graphs plotting the width of the Anillin zone (E) and the RhoA zone (F) m
are the Student’s t test; error bars represent SEM.
(G and H) Images of HeLa cells expressing Anillin::GFP. Representative time-lapse
shown for each condition.
(I) Cortical Anillin::GFP fluorescence measured using a pole-to-pole linescan 1
metaphase was subtracted from each value and the two linescans for each cell
See also Figure S5.
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to patterning of the active RhoA zone. Our results highlight the
importance in future work of elucidating the molecular basis of
the aster-based mechanism that constrains active RhoA to the
cell equator.
EXPERIMENTAL PROCEDURES
C. elegans Strains and RNAi
C. elegans strains and dsRNAs are listed in the Supplemental Experimental
Procedures. Strains containing integrated cyk-4 and rga-3 transgenes were
generated as described (Frøkjaer-Jensen et al., 2008). L4 hermaphrodites
were injected with dsRNA and incubated at 20C for 20–28 hr before dissec-
tion and embryo imaging. For embryo lethality tests, worms were singled
23–27 hr postinjection and allowed to lay embryos for 24 hr at 20C. Adult
worms were removed and hatched/inviable embryos were counted 24 hr later.
Microscopy, Immunofluorescence, and Image Analysis
For details on microscopy and immunofluorescence, see Supplemental
Experimental Procedures. Anillin::GFP accumulation (Figure 5D) was analyzed
3, 6, and 9min after the last metaphase frame (t = 0 min) in the central confocal
plane in which the cell was in best focus by drawing a 5 pixel-wide linescan en-
compassing the pole-pole cortex (excluding blebs and protrusions). Mean
cytoplasmic fluorescence intensity measured near the cell center was sub-
tracted and the mean Anillin::GFP fluorescence intensity in the 8 mm wide
region centered around the fluorescence peak calculated. All values were
normalized using the mean fluorescence intensity of control cells at 9 min.
Anillin::GFP zone width (Figure 5C) was measured using cortical pole-to-
pole linescans when the first bending of the cortex occurs (9 min after
anaphase onset); zone width was measured at half maximum fluorescence in-
tensity. Anillin and RhoA zone widths in fixed anaphase cells were similarly
measured using 8 pixel-wide pole-to-pole cortical linescans. In Figure 6I,
average metaphase cortical Anillin::GFP fluorescence intensity was sub-
tracted from cortical linescans performed 13.5 min after anaphase onset;
values were normalized by dividing by the average fluorescence intensity
between 40%–50% of cell length in control cells and two linescans per cell
were averaged. Anillin::GFP zone width in live cells was 2-fold larger than
RhoA/Anillin zone width in fixed cells. This difference is explained by larger
size of Anillin::GFP HeLa cells and is consistent with RhoA zones scaling
with cell size (Bement et al., 2005).
HeLa Cell Lines
All cell lines are listed in the Supplemental Experimental Procedures. H2B-
mRFP (Histone) and MyrPalm-mEGFP (Membrane) HeLa cells were obtained
from Daniel Gerlich (Steigemann et al., 2009). BAC-integrated mouse
Anillin::FLAP and human MP-GAP::LAP HeLa lines were generated using
BACs RP11-106G20 and RP23-73C5 (http://bacpac.chori.org) harboring
human ARHGAP11A and mouse ANLN, respectively. Tagging LAP (EGFP-
IRES-Neo) and FLAP (EGFP-FLAG-IRES-Neo) cassettes were PCR-amplified
using primers with 50 nucleotide homology. Recombineering and stable BAC
transfection were performed as described (Poser et al., 2008). Clonal lines
were obtained by fluorescence-activated cell sorting (FACS). Stable isogenic
HeLa lines expressing GFP::MP-GAP, GFP::MP-GAPGD, GFP::RhoA, and
GFP::RhoAQ63L were generated by FRT/Flp-mediated recombination (Gass-
mann et al., 2010; Tighe et al., 2004). RNAi resistance was conferred using
four silent mutations in MP-GAP (ATTACAGGCAGCTGTGGTG, changes
are underlined). Human MP-GAP and RhoA cDNA, as well as MP-GAPGD orned for DNA and RhoA.
easured as described in Figure 5C. n = number of linescans analyzed. P values
sequences (G) or three images of cells13.5 min after anaphase onset (H) are
3.5 min after anaphase onset. The average cortical fluorescence intensity at
were averaged to generate each individual trace. Scale bars represent 10 mm.
evier Inc.
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contain an N-terminal Myc-LAP epitope tag (Cheeseman and Desai, 2005;
Gassmann et al., 2010). Vectors were cotransfected in HeLa Flp-In T-Rex cells
with pOG44 encoding the Flp recombinase using X-tremeGENE 9 (Roche).
After selection with hygromycin, colonies were pooled and transgene expres-
sion induced with 0.2 mg/ml tetracycline.
Cell culture and siRNA transfection are described in the Supplemental
Experimental Procedures. Cells were fixed and stained or collected for immu-
noblotting 48 hr and 72 hr after transfection. Live-cell imaging was initiated
48 hr after transfection. Expression of GFP::MP-GAP and GFP::MP-GAPGD
was induced with 0.2 mg/ml tetracycline 24 hr after siRNA transfection and
cells were fixed 24 hr later. Expression of GFP::RhoA and GFP::RhoAQ63L
was induced 16 hr before imaging. MCAK siRNA cells (Rankin andWordeman,
2010) were fixed 30 hr after transfection. Nocodazole (Sigma-Aldrich) was
used at a final concentration of 10 nM. Unsynchronized HeLa cells were
treated with nocodazole or DMSO (control) for 10 min prior to fixation. In
Figures 6G–6I, HeLa cells expressing Anillin::GFP were transfected with
MP-GAP siRNA for 48 hr and nocodazole added 2–3 min after the last meta-
phase frame.
Human RhoGAP siRNA Screen
HeLa cells were seeded in 384-well plates (Aurora, FluidX) at a density of 500
cells/well. Twenty-four hours after seeding, a Freedom Evo 200 liquid handling
station (Tecan) and Oligofectamine (Life Technologies) were used to transfect
cells with 10 nM stealth siRNAs (Life Technologies). Seventy-two hours after
transfection, cells were fixed and stained using a plate washer (EL406, BioTek
and Powerwasher PW384, Tecan). Nine-plane z stacks (1.3 mm intervals) were
acquired for seven fields per well using an OPERA imaging system (Perkin
Elmer) equipped with a 403 water-immersion objective (NA = 0.9).
In Vitro GAP Assay
6xHis-taggedMP-GAPGAP domain (1–253 aa) was cloned into pET28 and ex-
pressed in BL21 E. coli. The GAP domain was purified (see Supplemental
Experimental Procedures), stored in 10% sucrose at 80C, and dialyzed
into 50 mM Tris, 150 mMNaCl, 1 mMMgCl2 prior to the analysis with RhoGAP
assay Biochem kit (BK105, Cytoskeleton).
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
five figures, one table, and five movies and can be found with this article online
at http://dx.doi.org/10.1016/j.devcel.2013.08.005.
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